Racial and ethnic disparities in Lyme disease in the United States

被引:2
作者
Gould, L. Hannah [1 ]
Fathalla, Adam [1 ]
Moisi, Jennifer C. [2 ]
Stark, James H. [3 ]
机构
[1] Pfizer Biopharm Grp, Global Med Affairs Vaccines & Antivirals, New York, NY 10001 USA
[2] Pfizer Biopharm Grp, Global Vaccines & Antivirals, Paris, France
[3] Pfizer Biopharm Grp, Global Vaccines & Antivirals, Cambridge, MA USA
关键词
Borrelia; equity; health disparities; Lyme disease; COUNTY; RISK;
D O I
10.1111/zph.13137
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Lyme disease (LD), caused by the spirochete Borrelia burgdorferi, is the most common vector-borne disease in the United States. Although most surveillance-reported cases are in people who are White, data suggest worse outcomes among people from racial and ethnic minority groups. Methods: We conducted a systematic literature review to describe racial disparities in LD. We described the epidemiology of LD by race and ethnicity, including clinical presentation at diagnosis, and summarised the literature on knowledge, attitudes and practices related to LD and ticks by race and ethnicity. Results: Overall, the incidence and prevalence of LD were 1.2-3.5 times higher in White persons than in persons who identified as Asian or Pacific Islander and 4.5-6.3 times higher in White persons than in persons who identified as Black. Across multiple studies, people from racial and ethnic minority groups were more likely than White people to have disseminated manifestations of LD, including neurological manifestations and arthritis, and less likely to have erythema migrans. People from racial and ethnic minority groups were also more likely to report disease onset in the fall and less likely to report disease onset in the summer. Possible reasons for these disparities include lack of recognition of the disease in people with darker skin tones, lack of knowledge of disease risk for some groups and differences in exposure risk. Conclusions: Taken together, these results reinforce that all people residing in high-incidence areas are at risk of LD, regardless of race or ethnicity. Future prevention measures should be broadly targeted to reach all at-risk populations.
引用
收藏
页码:469 / 479
页数:11
相关论文
共 55 条
[1]  
Abul Y, 2016, OPEN FORUM INFECT DI, V3, DOI [10.1093/ofid/ofw172.1125, 10.1093/ofid/ofw172.1125, DOI 10.1093/OFID/OFW172.1125]
[2]   Health Care Costs, Utilization and Patterns of Care following Lyme Disease [J].
Adrion, Emily R. ;
Aucott, John ;
Lemke, Klaus W. ;
Weiner, Jonathan P. .
PLOS ONE, 2015, 10 (02)
[3]   The Rise and Fall of the Lyme Disease Vaccines: A Cautionary Tale for Risk Interventions in American Medicine and Public Health [J].
Aronowitz, Robert A. .
MILBANK QUARTERLY, 2012, 90 (02) :250-277
[4]  
Artiga S., 2023, Survey on racism, discrimination and health: Experiences and impacts across racial and ethnic groups
[5]  
California Department of Public Health, 2021, EPIDEMIOLOGIC SUMMAR
[6]  
Centers for Disease Control and Prevention, 2023, DMI HLTH EQUITY
[7]  
Centers for Disease Control and Prevention, 2023, SURVEILLANCE DATA
[8]  
Chow CC, 2003, MT SINAI J MED, V70, P207
[9]  
Chow R, 2017, OPEN FORUM INFECT DI, V4, pS588, DOI [10.1093/ofid/ofx163.1544, 10.1093/ofid/ofx163.1544, DOI 10.1093/OFID/OFX163.1544]
[10]   Socio-ecological drivers of multiple zoonotic hazards in highly urbanized cities [J].
Combs, Matthew A. ;
Kache, Pallavi A. ;
VanAcker, Meredith C. ;
Gregory, Nichar ;
Plimpton, Laura D. ;
Tufts, Danielle M. ;
Fernandez, Maria P. ;
Diuk-Wasser, Maria A. .
GLOBAL CHANGE BIOLOGY, 2022, 28 (05) :1705-1724